EMA guideline on investigational ATMPs

The guideline adopted by EMA’s CHMP Committee on 20 January 2025 will come into force on 1 July. It discusses in detail all the different aspects to be considered during the development of an investigational advanced therapy medicinal product, both in exploratory and confirmatory studies, in order to prepare a submission dossier adequate to support application for marketing authorisation

The proposal of a Critical Medicines Act

The Critical Medicines Act proposed by the European Commission aims to overcome supply issues and shortages of medicinal products by mean of the activation of Strategic Projects, new procurement requirements and improved international partnerships

The Clean Industrial Deal and the Omnibus package on simplification

The European Commission published the Clean Industrial Deal on 26 February 2025, detailing the strategy that should support the final transition to the new models based on decarbonisation, electrification, innovation and reindustrialisation of the European Union. The first two Omnibus packages of measures aimed to lower energy prices, simplify procedures for companies and improve the InvestEU regulation were also released and will now undergo examination by the EU Parliament and Council